» Articles » PMID: 26915573

Macrocyclic Gadolinium-Based Contrast Agents Do Not Cause Hyperintensity in the Dentate Nucleus

Overview
Specialty Neurology
Date 2016 Feb 27
PMID 26915573
Citations 5
Authors
Affiliations
Soon will be listed here.
Citing Articles

Practical recommendations for the safe use of gadolinium in magnetic resonance imaging: a Delphi expert panel study.

Baroni R, Bauab Jr T, Bittencourt L, DIppolito G, Goldman S, Hohgraefe Neto G Radiol Bras. 2020; 53(4):216-222.

PMID: 32904664 PMC: 7458558. DOI: 10.1590/0100-3984.2019.0074.


Brain tissue gadolinium retention in pediatric patients after contrast-enhanced magnetic resonance exams: pathological confirmation.

Stanescu A, Shaw D, Murata N, Murata K, Rutledge J, Maloney E Pediatr Radiol. 2020; 50(3):388-396.

PMID: 31989188 DOI: 10.1007/s00247-019-04535-w.


Gadolinium Deposition in Neurology Clinical Practice.

Smith T, Steven A, Bagert B Ochsner J. 2019; 19(1):17-25.

PMID: 30983897 PMC: 6447198. DOI: 10.31486/toj.18.0111.


Increased variability of watershed areas in patients with high-grade carotid stenosis.

Kaczmarz S, Griese V, Preibisch C, Kallmayer M, Helle M, Wustrow I Neuroradiology. 2018; 60(3):311-323.

PMID: 29299616 DOI: 10.1007/s00234-017-1970-4.


Biological effects of MRI contrast agents: gadolinium retention, potential mechanisms and a role for phosphorus.

Garcia J, Liu S, Louie A Philos Trans A Math Phys Eng Sci. 2017; 375(2107).

PMID: 29038383 PMC: 5647271. DOI: 10.1098/rsta.2017.0180.

References
1.
Radbruch A, Weberling L, Kieslich P, Hepp J, Kickingereder P, Wick W . High-Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted Images: Evaluation of the Macrocyclic Gadolinium-Based Contrast Agent Gadobutrol. Invest Radiol. 2015; 50(12):805-10. DOI: 10.1097/RLI.0000000000000227. View

2.
Stojanov D, Aracki-Trenkic A, Vojinovic S, Benedeto-Stojanov D, Ljubisavljevic S . Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based.... Eur Radiol. 2015; 26(3):807-15. DOI: 10.1007/s00330-015-3879-9. View

3.
Kanda T, Fukusato T, Matsuda M, Toyoda K, Oba H, Kotoku J . Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy. Radiology. 2015; 276(1):228-32. DOI: 10.1148/radiol.2015142690. View

4.
Kanda T, Oba H, Toyoda K, Kitajima K, Furui S . Brain gadolinium deposition after administration of gadolinium-based contrast agents. Jpn J Radiol. 2015; 34(1):3-9. DOI: 10.1007/s11604-015-0503-5. View

5.
McDonald R, McDonald J, Kallmes D, Jentoft M, Murray D, Thielen K . Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging. Radiology. 2015; 275(3):772-82. DOI: 10.1148/radiol.15150025. View